Login to Your Account

Financings roundup

Thursday, May 8, 2014
Celgene Corp. priced three series of senior unsecured notes for an offering it expects will raise about $2.5 billion.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription